BG106079A - Cyclocarbamate derivatives as progesterone receptor modulators - Google Patents

Cyclocarbamate derivatives as progesterone receptor modulators

Info

Publication number
BG106079A
BG106079A BG106079A BG10607901A BG106079A BG 106079 A BG106079 A BG 106079A BG 106079 A BG106079 A BG 106079A BG 10607901 A BG10607901 A BG 10607901A BG 106079 A BG106079 A BG 106079A
Authority
BG
Bulgaria
Prior art keywords
substituted
alkyl
alkoxy
aminoalkyl
alkynyl
Prior art date
Application number
BG106079A
Other languages
Bulgarian (bg)
English (en)
Inventor
Puwen Zhang
Eugene Teferenko
Andrew Fensome
Jay Wrobel
James Edwards
Todd Jones
Christopher Tegley
Lin Zhi
III Horace FLETCHER
Original Assignee
Ligand Pharmaceuticals, Inc.
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by Ligand Pharmaceuticals, Inc., Wyeth filed Critical Ligand Pharmaceuticals, Inc.
Publication of BG106079A publication Critical patent/BG106079A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG106079A 1999-05-04 2001-11-02 Cyclocarbamate derivatives as progesterone receptor modulators BG106079A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011822 WO2000066571A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
BG106079A true BG106079A (en) 2002-05-31

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106079A BG106079A (en) 1999-05-04 2001-11-02 Cyclocarbamate derivatives as progesterone receptor modulators

Country Status (19)

Country Link
EP (1) EP1173426A1 (cg-RX-API-DMAC10.html)
JP (1) JP2002543193A (cg-RX-API-DMAC10.html)
KR (1) KR20010114250A (cg-RX-API-DMAC10.html)
CN (1) CN1145618C (cg-RX-API-DMAC10.html)
AU (1) AU766428B2 (cg-RX-API-DMAC10.html)
BG (1) BG106079A (cg-RX-API-DMAC10.html)
BR (1) BR0010213A (cg-RX-API-DMAC10.html)
CA (1) CA2371726A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20013951A3 (cg-RX-API-DMAC10.html)
EA (1) EA004512B1 (cg-RX-API-DMAC10.html)
HU (1) HUP0201609A3 (cg-RX-API-DMAC10.html)
IL (1) IL146280A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA01011286A (cg-RX-API-DMAC10.html)
NO (1) NO321361B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ515355A (cg-RX-API-DMAC10.html)
PL (1) PL351127A1 (cg-RX-API-DMAC10.html)
SG (1) SG114650A1 (cg-RX-API-DMAC10.html)
SK (1) SK15912001A3 (cg-RX-API-DMAC10.html)
TR (1) TR200103286T2 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5108506B2 (ja) * 2004-04-27 2012-12-26 ワイス・エルエルシー シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
US20100160304A1 (en) * 2005-01-19 2010-06-24 Dainippon Sumitomo Pharma Co., Ltd Aromatic sulfone compound as aldosterone receptor modulator
WO2009044788A1 (ja) 2007-10-05 2009-04-09 Banyu Pharmaceutical Co., Ltd. ベンゾオキサジノン誘導体
CN111925353B (zh) * 2020-08-31 2022-04-08 苏州大学附属第二医院 一种2-噻吩甲腈的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
AU717251B2 (en) * 1994-12-22 2000-03-23 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
DE69724630T2 (de) * 1996-10-02 2004-07-29 Bristol-Myers Squibb Pharma Co. 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv-reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
CA2371726A1 (en) 2000-11-09
NZ515355A (en) 2004-02-27
AU4688600A (en) 2000-11-17
EA004512B1 (ru) 2004-04-29
SG114650A1 (en) 2005-09-28
PL351127A1 (en) 2003-03-24
EA200101176A1 (ru) 2002-04-25
TR200103286T2 (tr) 2002-07-22
NO20015378L (no) 2002-01-03
CZ20013951A3 (cs) 2002-05-15
MXPA01011286A (es) 2003-07-14
CN1145618C (zh) 2004-04-14
SK15912001A3 (sk) 2002-06-04
NO20015378D0 (no) 2001-11-02
BR0010213A (pt) 2002-02-19
HUP0201609A2 (en) 2002-08-28
HUP0201609A3 (en) 2002-12-28
IL146280A0 (en) 2002-07-25
AU766428B2 (en) 2003-10-16
JP2002543193A (ja) 2002-12-17
CN1349517A (zh) 2002-05-15
EP1173426A1 (en) 2002-01-23
NO321361B1 (no) 2006-05-02
KR20010114250A (ko) 2001-12-31

Similar Documents

Publication Publication Date Title
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
WO2000066564A8 (en) Benzimidazolones and analogues and their use as progesterone receptor ligands
NO20004778L (no) Amidderivater og nociceptin antagonister
BR0109855A (pt) Derivados de 8-isoquinolinxantina e 8-quinolixantina como inibidores de pde 5
UA74391C2 (uk) Арил- або гетероарилконденсовані імідазоли як антизапальні і анальгетичні агенти
HUP0300641A2 (hu) Triazaspiro[5.5]undekán-származékok és hatóanyagként ezeket tartalmazó gyógyszerkészítmények
ATE152719T1 (de) Chinolylbenzofuran derivate als leukotrien- antagonisten
MX9504349A (es) Derivados de aroilpiperidina.
MXPA02012447A (es) Antagonistas receptores de trombina.
BG102637A (en) Tropane derivatives, their preparation and application
MX9709951A (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
DE60140456D1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
DK1173433T3 (da) Cyanopyrroler som progesteronreceptoragonister
DK0583485T3 (da) Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger
BG106080A (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
NO964698D0 (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
HUP0204354A2 (hu) Új heterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
CO5540322A2 (es) Nuevos derivados heterociclicos que comprenden un anillo de tetrahidroisoquinolina y uso farmaceutico de los mismos
CO5160261A1 (es) Derivados de bifenilo sustituidos que son antagonistas nk-1, su procedimiento de sintesis y composiciones farmaceuticas que los contienen
NZ515355A (en) Cyclocarbamate derivatives as progesterone receptor modulators
ES2174220T3 (es) Uso de derivados de 4-fenil-3,6-dihidro-2h-piridilo como agentes bloqueantes de subtipos de receptores nmda.
GEP20043221B (en) Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Pharmaceutical Composition Containing Them and Use Thereof for Treatment Progesterone-Related Maladies.
HK1043991A1 (zh) 作為黃體酮受體調節劑的喹唑啉酮及苯並噁嗪衍生物
YU38498A (sh) Derivati 2-(arilfenil)amino-imidazolina
TWI265032B (en) Pharmaceutically useful kits comprising progesterone receptor modulators